Key regulatory pathways—including PDGF-BB, TGF-β, MAPK, mTOR, and NF-κB—as well as non-coding RNAs, orchestrate this process in response to endothelial dysfunction, inflammatory activation, and altered hemodynamics. The gene discussed is NFKB1; the disease is endothelial dysfunction.